Krams Indrikis A, Luoto Severi, Rantala Markus J, Jõers Priit, Krama Tatjana
Latvian Biomedical Research and Study Centre, LV-1067 Riga, Latvia.
Institute of Ecology and Earth Sciences, University of Tartu, EE-51010 Tartu, Estonia.
Pathogens. 2020 Oct 26;9(11):887. doi: 10.3390/pathogens9110887.
Although obesity is known to be a risk factor for COVID-19 severity, there is an urgent need to distinguish between different kinds of fat-visceral and subcutaneous fat-and their inflammation status in COVID-19. These different fat types have partially diverging biochemical roles in the human body, and they are differentially associated with SARS-CoV-2, which targets the angiotensin-converting enzyme 2 (ACE2) for cell entry. ACE2 is highly expressed in adipose tissue, especially in visceral fat, suggesting an important role for this tissue in determining COVID-19 disease severity. In this perspective article, we discuss group differences in the amount of visceral fat levels and the extent of inflammation in adipocytes of visceral fat tissue, which may, in part, drive population, cross-national, ethnic, and sex differences in COVID-19 disease. It is vital to steer the scientific community's attention to the effects of visceral fat in creating individual and population differences in COVID-19 severity. This can help researchers unravel the reasons for the reported population, ethnic, and sex differences in COVID-19 severity and mortality.
尽管肥胖是已知的导致新冠病毒疾病严重程度的风险因素,但迫切需要区分不同类型的脂肪——内脏脂肪和皮下脂肪——以及它们在新冠病毒疾病中的炎症状态。这些不同类型的脂肪在人体中具有部分不同的生化作用,并且它们与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的关联也有所不同,SARS-CoV-2通过靶向血管紧张素转换酶2(ACE2)进入细胞。ACE2在脂肪组织中高度表达,尤其是在内脏脂肪中,这表明该组织在决定新冠病毒疾病严重程度方面具有重要作用。在这篇观点文章中,我们讨论了内脏脂肪水平数量以及内脏脂肪组织中脂肪细胞炎症程度的群体差异,这些差异可能在一定程度上导致了新冠病毒疾病在人群、跨国、种族和性别方面的差异。引导科学界关注内脏脂肪在造成新冠病毒疾病严重程度的个体和群体差异方面的作用至关重要。这有助于研究人员揭示报告中新冠病毒疾病严重程度和死亡率在人群、种族和性别方面存在差异的原因。